News
This was the stock's third consecutive day of losses.
In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
This was the stock's third consecutive day of losses.
15h
Zacks Investment Research on MSNHow Will Pfizer's Oncology Drugs Perform in Q2 Earnings?Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results